NCT07720102Enrolling by invitation
Patient Reported Outcomes Following Percutaneous Lung Ablation
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 17 Jul 2026
- Start date
- 13 Aug 2026
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- Mayo Clinic
- Diseases
- Lung cancer
- NCT number
- NCT07720102
What you commit to
- Study type: Observational
- Planned participants: 50
- From 13 Aug 2026 to the primary completion date, 31 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Decline to participate in research
Who the study is looking for
- Undergoing percutaneous lung ablation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.